Protective Coating for Wound Fluid Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Wound treatment fluids with active molecules often degrade when exposed to materials or light, reducing their effectiveness in delivering therapeutic benefits to the wound site due to lack of protection during delivery and application in existing systems.

Innovation Solution

A wound treatment system that includes a fluid storage device with molecules coated for protection, coupled with an energy source that degrades the protective coating at the wound site, activating the therapeutic properties of the fluid, which can include anti-biotic, analgesic, or debridement properties, using various energy forms like ultrasonic, magnetic, or light energy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If wound treatment fluids are delivered through tubing and plastic components, then the fluid can be transported to the wound site, but the active molecules in the fluid degrade due to contact with materials and light exposure

Engineering Contradiction:
Improveeffectiveness of active moleculesVSAvoiddegradation from material contact and light
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by coating active molecules with a protective layer before delivery through the system. This protective coating prevents degradation during transport through tubing and exposure to light, ensuring the molecules remain effective until they reach the wound site where they are then activated

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The protective coating acts as an intermediary between the active molecules and the harmful environment (tubing materials and light). This intermediary layer shields the sensitive molecules during delivery while allowing controlled activation at the target site

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If protective coating is applied to active molecules, then degradation during delivery is prevented, but the therapeutic property remains inactive until activation

Engineering Contradiction:
Improvestability during transportVSAvoidactivation timing control
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The protective coating is applied in advance to protect molecules during storage and transport. The coating remains in place until the fluid reaches the wound site, where controlled activation occurs through energy input (such as light or heat), converting the protected state to the active therapeutic state at the appropriate time

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If energy source is used to activate therapeutic property at wound site, then accurate activation is achieved, but system complexity increases

Engineering Contradiction:
Improveactivation location precisionVSAvoidenergy source and control system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system utilizes the wound site environment itself to trigger activation. For example, the body's natural heat or light exposure at the wound site can activate the therapeutic molecules without requiring complex external energy delivery systems, thereby achieving precise local activation while minimizing added system complexity

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach ensures the accurate activation of therapeutic properties at the wound site, minimizing degradation and enhancing the efficacy of wound treatment by maintaining the potency of the active agents during transport and application, thereby improving healing and dressing removal processes.

Implementation Method 1

an energy source configured to direct energy to the fluid and to activate a therapeutic property of the fluid

Methodology Applied
Scientific EffectPhotochemical degradation: Photodissociation

Data Source

PatentUS10406337B2Systems and methods of stimulation and activation of fluids for use with instillation therapy
Publication Date: 2019.09.10 SOLVENTUM INTELLECTUAL PROPERTIES CO
  • US10406337B2 patent drawing
  • US10406337B2 patent drawing

AI summary

Systems and methods of stimulating or activating fluids for use in wound treatment systems.